Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2012, Article ID 368528, 8 pages
http://dx.doi.org/10.1155/2012/368528
Clinical Study

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer

1Department of Radiotherapy, Ghent University Hospital, 9000 Ghent, Belgium
2Department of Urology, Ghent University Hospital, 9000 Ghent, Belgium
3Department of Radiology, Ghent University Hospital, 9000 Ghent, Belgium

Received 7 June 2011; Accepted 21 September 2011

Academic Editor: Martin Spahn

Copyright © 2012 Valérie Fonteyne et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Moore, P. Dimitropoulou, A. Lane et al., “Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer,” BJU International, vol. 104, no. 11, pp. 1592–1598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Anscher, R. Clough, and R. Dodge, “Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years,” International Journal of Radiation Oncology Biology Physics, vol. 48, no. 2, pp. 369–375, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Coen, A. L. Zietman, H. Thakral, and W. U. Shipley, “Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases,” Journal of Clinical Oncology, vol. 20, no. 15, pp. 3199–3205, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. P. B. Morgan, A. L. Hanlon, E. M. Horwitz, M. K. Buyyounouski, R. G. Uzzo, and A. Pollack, “Radiation dose and late failures in prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 67, no. 4, pp. 1074–1081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Jacob, A. L. Hanlon, E. M. Horwitz, B. Movsas, R. G. Uzzo, and A. Pollack, “The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer,” Cancer, vol. 100, no. 3, pp. 538–543, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. P. Dearnaley, M. R. Sydes, J. D. Graham et al., “Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial,” The Lancet Oncology, vol. 8, no. 6, pp. 475–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Pollack, G. K. Zagars, G. Starkschall et al., “Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 5, pp. 1097–1105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. L. Zietman, K. Bae, J. D. Slater et al., “Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09,” Journal of Clinical Oncology, vol. 28, no. 7, pp. 1106–1111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. A. Viani, E. J. Stefano, and S. L. Afonso, “Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 5, pp. 1405–1418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Zelefsky, V. E. Reuter, Z. Fuks, P. Scardino, and A. Shippy, “Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer,” Journal of Urology, vol. 179, no. 4, pp. 1368–1373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. P. Dearnaley, V. S. Khoo, A. R. Norman et al., “Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial,” The Lancet, vol. 353, no. 9149, pp. 267–272, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. V. Pilepich, K. Winter, C. A. Lawton et al., “Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85-31,” International Journal of Radiation Oncology Biology Physics, vol. 61, no. 5, pp. 1285–1290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Bolla, L. Collette, L. Blank et al., “Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial,” The Lancet, vol. 360, no. 9327, pp. 103–108, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. G. O. de Meerleer, V. H. Fonteyne, L. Vakaet et al., “Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control,” Radiotherapy and Oncology, vol. 82, no. 2, pp. 160–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Fonteyne, G. Villeirs, B. Speleers et al., “Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 3, pp. 799–807, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Fonteyne, W. de Gersem, W. de Neve et al., “Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 4, pp. 1013–1020, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. American Joint Committee on Cancer, “Prostate,” in AJCC Cancer Staging Manual, 6th edition, pp. 309–316, Springer, New York, NY, USA, 2002. View at Google Scholar
  18. P. Ost, B. Speleers, G. de Meerleer et al., “Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: planning comparison study,” International Journal of Radiation Oncology Biology Physics, vol. 79, no. 3, pp. 920–926, 2011. View at Publisher · View at Google Scholar
  19. V. Fonteyne, G. Villeirs, N. Lumen, and G. de Meerleer, “Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer,” Radiotherapy and Oncology, vol. 92, no. 1, pp. 42–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Fonteyne, W. de Neve, G. Villeirs, C. de Wagter, and G. de Meerleer, “Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity,” Radiotherapy and Oncology, vol. 84, no. 2, pp. 156–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Roach III, G. Hanks, H. Thames Jr. et al., “Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference,” International Journal of Radiation Oncology Biology Physics, vol. 65, no. 4, pp. 965–974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Widmark, O. Klepp, A. Solberg et al., “Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial,” The Lancet, vol. 373, no. 9660, pp. 301–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Merglen, F. Schmidlin, G. Fioretta et al., “Short- and long-term mortality with localized prostate cancer,” Archives of Internal Medicine, vol. 167, no. 18, pp. 1944–1950, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Akakura, H. Suzuki, T. Ichikawa et al., “A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months,” Japanese Journal of Clinical Oncology, vol. 36, no. 12, pp. 789–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Boorjian, R. J. Karnes, R. Viterbo et al., “Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer,” Cancer, vol. 117, no. 13, pp. 2883–2891, 2011. View at Publisher · View at Google Scholar
  26. S. G. Fletcher, S. E. Mills, M. E. Smolkin, and D. Theodorescu, “Case-Matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 4, pp. 1092–1099, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. J. Zelefsky, Y. Yamada, M. A. Kollmeier, A. M. Shippy, and M. A. Nedelka, “Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer,” European Urology, vol. 53, no. 6, pp. 1172–1179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Zelefsky, E. J. Levin, M. Hunt et al., “Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 4, pp. 1124–1129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. L. Zietman, M. L. DeSilvio, J. D. Slater et al., “Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial,” Journal of the American Medical Association, vol. 294, no. 10, pp. 1233–1239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. T. H. Peeters, W. D. Heemsbergen, P. C. M. Koper et al., “Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 1990–1996, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C. A. Lawton, M. DeSilvio, M. Roach III et al., “An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions,” International Journal of Radiation Oncology Biology Physics, vol. 69, no. 3, pp. 646–655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Pommier, S. Chabaud, J. L. Lagrange et al., “Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01,” Journal of Clinical Oncology, vol. 25, no. 34, pp. 5366–5373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. E. Vargas, R. Galalae, J. Demanes et al., “Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 5, pp. 1474–1482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. T. A. Masterson, F. J. Bianco Jr., A. J. Vickers et al., “The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer,” Journal of Urology, vol. 175, no. 4, pp. 1320–1324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. A. Joslyn and B. R. Konety, “Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer,” Urology, vol. 68, no. 1, pp. 121–125, 2006. View at Publisher · View at Google Scholar · View at Scopus